GME Geratherm Medical AG
Geratherm Medical AG, a medical technology company, develops, produces, and markets medical products for measuring vital data in Germany. It operates through Healthcare Diagnostic, Respiratory, and Incubator Systems segments. The Healthcare Diagnostic segment offers medical temperature measurement products, including mercury-free glass fever thermometer. Its Respiratory segment develops, produces, and sells lung function measuring devices. The Incubator Systems segment offers MRI-compatible incubators for premature infants. The company markets its products through pharmacies, hospitals, and clinics. It exports its products to approximately 60 countries. The company was founded in 1990 and is headquartered in Geschwenda, Germany.…
Industry Peers
Medical DevicesKey Statistics
About Geratherm Medical (ETR: GME)
›
Geratherm Medical (ETR: GME) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 136 employees.
The shares were at 2.130 EUR on 19 November 2026, down 36.6% over 52 weeks. Its 52-week range is 1.950 EUR to 3.680 EUR: the price is 42.1% below the high and 9.2% above the low.
Its market capitalisation is 11.53M EUR. It pays a dividend yielding 4.74% (it pays out 29% of its earnings), against a median of 2.36% among the dividend payers in that peer group.
Geratherm Medical reports return on equity of -4.2%, an operating margin of -9.5% and revenue down 12.5% year over year.
It holds more cash than debt, a net cash position of 6.62M EUR. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 4.000 EUR is 87.8% above the current price.